Koyabu S, Onaka T, Imada K. Ponatinib may make allogeneic hematopoietic stem cell transplantation unnecessary for CML-BC under specific conditions, such as de novo cases: a case series of de novo CML-BC treated with ponatinib and no transplantation. Leuk Lymphoma 2025 Jun 25:1-4. doi: 10.1080/10428194.2025.2521646.
PMID: 40561048